Australia & South Korea Diabetic Foot Ulcer Market to Grow at a CAGR of 5.8% to reach US$ 313.53 billion from 2022 to 2030
市场洞察和分析师观点:
糖尿病足溃疡是病情不佳的糖尿病患者最常见的并发症受控。溃疡发生在受压部位的老茧内,通常是无痛的,导致诊断和治疗的延误。大约 15% 的糖尿病患者通常会出现开放性溃疡或伤口。糖尿病足溃疡也会影响患有糖尿病相关肾脏、皮肤或心脏病的患者;肥胖患者;以及高风险饮酒量的人。糖尿病和相关慢性伤口的高患病率以及老年人口的激增正在推动澳大利亚和韩国糖尿病足溃疡市场的发展。然而,先进伤口护理治疗的高成本阻碍了澳大利亚和韩国糖尿病足溃疡市场的增长。
增长动力和挑战:
糖尿病患者容易受伤,愈合过程通常较长。根据愈合时间,伤口分为急性和慢性。根据澳大利亚健康与福利研究所的数据,到 2021 年,超过 130 万(每 20 人中就有 1 人)患有糖尿病。在韩国,糖尿病的患病率正在上升,给经济、医疗保健系统和社会带来了重大挑战。据韩国糖尿病协会统计,2020年,韩国30岁以上人群的糖尿病患病率为16.7%。糖尿病患者足部的血管和神经容易受损,导致麻木。因此,糖尿病患者患糖尿病足溃疡的机会较高。根据国家生物技术信息中心 (NCBI) 的数据,近 15-25% 的糖尿病患者在其一生中可能会出现糖尿病足溃疡 (DFU)。由于糖尿病,澳大利亚每年有超过 4,400 例截肢手术,这一比例在发达国家中位居第二。根据澳大利亚糖尿病足协会和澳大利亚糖尿病协会2020年发布的数据,每年约有5万名澳大利亚人患上糖尿病相关足病(DFD),另有30万人有患糖尿病相关足病的危险因素。因此,澳大利亚和韩国对糖尿病足溃疡治疗的需求正在上升。
年龄相关糖尿病在澳大利亚和韩国很常见。根据澳大利亚健康与福利研究所 2021 年发布的数据,80-84 岁的澳大利亚人中近五分之一患有糖尿病;该年龄组的发病率比 40 岁以下人群 (0.7%) 高出近 30 倍。根据韩国统计局的报告,到 2021 年,65 岁及以上的人口将达到 853 万人。该报告还估计,到 2050 年,老年人数量可能占该国人口的 43.9%。然而,伤口护理治疗仍需进行。当受伤的皮肤失去愈合能力时,这使得手术变得昂贵。根据澳大利亚糖尿病协会发布的数据,估计澳大利亚每年因糖尿病足病花费约8.75亿美元。此外,与糖尿病相关的截肢手术费用近 23,555 美元,每年额外的术后费用为 6,065 美元。五年多来,与糖尿病相关的截肢费用为卫生系统带来了近 50,000 美元(不包括社会成本)。伤口的面积和手术的复杂程度也决定了治疗的费用。因此,尽管可以报销,但先进伤口护理治疗的高成本是限制澳大利亚和韩国糖尿病足溃疡市场增长的关键因素。
报告细分和范围:
“澳大利亚和韩国糖尿病足溃疡市场”根据溃疡类型、治疗类型、感染严重程度、最终用户和国家进行细分。
细分分析:
根据溃疡类型,澳大利亚和韩国糖尿病足溃疡市场分为神经性溃疡、缺血性溃疡和神经缺血性溃疡。到 2022 年,神经缺血性溃疡细分市场在澳大利亚和韩国糖尿病足溃疡市场中占据最大份额,预计在预测期内复合年增长率最高。糖尿病患者容易受伤,而且愈合过程通常较长。神经缺血主要导致足部、脚趾和背部边缘发生溃疡,特别是在使用不合脚鞋子的人中发生的压力部位。此类伤口的处理相对复杂。伤口需要及时护理、合适的鞋子、卸载、敷料和感染治疗。然而,神经缺血性溃疡是最常见的糖尿病足溃疡。神经缺血性溃疡是由患有周围神经病变和缺血的患者引起的,从而导致周围动脉疾病。神经缺血性溃疡的治疗包括转诊、清创、鞋类改造以及通过血管手术和抗生素等适当药物治疗感染。此外,伤口需要定期保持清洁,血糖水平必须在一定范围内,以避免任何可能的并发症。
澳大利亚和韩国糖尿病足溃疡市场,按治疗类型细分为高级伤口护理敷料、生物制剂和治疗设备。到 2022 年,先进伤口护理敷料细分市场在澳大利亚和韩国糖尿病足溃疡市场中占据最大份额。预计生物制剂细分市场在 2022 年至 2030 年期间复合年增长率最高,为 6.4%。
仅标准护理治疗通常不足以治愈糖尿病足溃疡伤口,需要随后或同时应用辅助伤口治疗,包括生物皮肤替代品。生物制品是从天然来源开发的,包括人类、动物和微生物。基于细胞的生物替代品特别用于治疗伤口。
区域分析:
根据国家/地区,澳大利亚和韩国糖尿病足溃疡市场分为澳大利亚和韩国。由于糖尿病病例不断增加,韩国占据了更大的市场份额。糖尿病是全国范围内的一个重大公共卫生问题,预计其负担在未来几年将增加。根据韩国《伤口管理与研究杂志》发表的题为《糖尿病足溃疡中的足底前足重建:穿支瓣膜和意外瓣膜的比较研究》的研究,2021 年,患有糖尿病足部问题的患者数量有所增加约占总人口的 1.4%,每年出现总人口的 0.4%。根据2012-2018年国家健康与营养调查结果,30岁以上的人中,每7人就有1人患有糖尿病,即韩国成年人口的13.8%。年龄越大,糖尿病患病率越高。在韩国,40多岁男性和50多岁女性的糖尿病患病率超过10%。据估计,15-25% 的糖尿病患者会在某个时候出现足部溃疡,其中一半以上会出现与感染相关的其他并发症。在极端情况下,约 20% 的中度至重度感染需要截肢。因此,随着老年人口的增加,糖尿病患者的数量预计也会增加,这反过来又将推动韩国糖尿病足溃疡市场的增长。
公共和私营企业之间日益加强的合作也正在推动澳大利亚和南非足部溃疡治疗市场的增长。 Lescarden Inc. 与 Daewoong Pharmaceutical Co., Ltd.(韩国首尔)签订许可协议,授予 Daewoong 在韩国销售 Catrix(R) 糖尿病足溃疡伤口敷料的 10 年独家许可。其专有产品Catrix (R) 伤口敷料是一种从特殊加工的牛软骨中提取的生物化合物。 FDA 和欧盟已批准该化合物用于治疗糖尿病足溃疡。 2019 年 2 月,韩国医疗初创公司 ROKIT Healthcare 提出了一种激进的再生解决方案,通过使用专有的三维生物打印策略来治疗糖尿病足溃疡。此外,2021 年 9 月,Rokit Healthcare Inc. 的 Dfurege 获得了韩国食品药品安全部 (MFDS) 的批准,这是一种用于治疗糖尿病足溃疡的人造器官平台。
因此,老年人口不断增长,糖尿病病例不断增加,以及激增的合作和产品批准推动了韩国糖尿病足溃疡市场的发展。
竞争格局和主要公司:
澳大利亚和韩国糖尿病足溃疡市场的发展被描述为有机和无机增长战略。许多公司都专注于有机增长战略,例如启动、扩张、增强和搬迁。澳大利亚和韩国糖尿病足溃疡市场的无机增长策略是并购、伙伴关系和合作。这些活动为扩大澳大利亚和韩国糖尿病足溃疡市场参与者的业务和客户群铺平了道路。
2023 年 1 月,MiMedx Group, Inc. 与 GUNZE MEDICAL LIMITED(“Gunze Medical”),Gunze Limited 的子公司,负责在日本销售 EPIFIX。 Gunze Medical 是广泛用于伤口和手术环境的产品的领先分销商,产品包括生物可吸收设备和材料,如缝合线和床单产品。2021 年 8 月,URGO Medical 与澳大利亚糖尿病足协会 (DFA) 合作。作为其章程的一部分,DFA 一直致力于为澳大利亚医疗保健部门制定糖尿病相关足病的循证指南,该指南将作为新的国家多学科最佳实践护理标准,在澳大利亚境内提供糖尿病足病护理。澳大利亚。2019 年 10 月,3M 收购了 Acelity, Inc. 及其全球 KCI 子公司。 Acelity 是一家全球领先的医疗技术公司,专注于在其 KCI 品牌下提供先进的伤口护理和特种手术解决方案。此次收购进一步巩固了 3M 作为高级伤口护理市场领导者的地位。 2023 年 4 月,3M Health Care 的创新 3M Veraflo Therapy(包括 3M Veraflo Cleanse Choice Complete Dressing 和 3M VAC)获得美国食品药品监督管理局 (FDA) 批准Veraflo Cleanse Choice 敷料,有助于水力机械去除感染性物质、非活性组织和伤口碎片。该产品还减少了所需的手术清创次数,同时促进肉芽组织形成并创造促进伤口愈合的环境。 2022 年 7 月,Smith + Nephew 推出了 WOUND COMPASS 临床支持应用程序。它是为医疗保健专业人员提供的综合数字支持工具,可帮助伤口评估和决策,以帮助减少实践差异。该应用程序有助于提高护士在评估和治疗伤口时的信心,并让专科护士放心,他们的处方得到遵守。2022 年 3 月,Convatec 通过收购 Triad Life Sciences Inc. 进入有吸引力的伤口生物制剂领域。该公司开发生物衍生的创新产品,以解决未满足的临床问题与手术伤口、慢性伤口和烧伤相关的需求。公司简介
MiMedx Group, IncConvatec Group PlcURGO MEDICAL Australia Pty Ltd3MOOrganogenesis Inc.Smith+NephewColoplast ASB。 Braun SEMolnlycke 医疗保健 ABMedline Industries LP
![Report Coverage](https://www.theinsightpartners.com/assets/rdimages/report_coverage.png)
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
![Segment Covered](https://www.theinsightpartners.com/assets/rdimages/segment_covered.png)
Segment Covered
This text is related
to segments covered.
![Regional Scope](https://www.theinsightpartners.com/assets/rdimages/regional_scope.png)
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
![Country Scope](https://www.theinsightpartners.com/assets/rdimages/country_scope.png)
Country Scope
This text is related
to country scope.
The List of Companies - Australia and South Korea Diabetic Foot Ulcer Market
- CONVATEC GROUP PLC
- 3M CO
- COLOPLAST A/S
- SMITH & NEPHEW PLC
- B. BRAUN SE
- MOLNLYCKE HEALTH CARE
- MIMEDX GROUP INC
- URGO MEDICAL AUSTRALIA PTY LTD
- MEDLINE INDUSTRIES LP
- ORGANOGENESIS INC
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.